Drug intelligence / Profile preview

6-aminopenicillanic acid

Development stage
Unknown
Lead developer
GSK
Modality
Small Molecules
Administration
None
01

Overview

6-aminopenicillanic acid is a small molecule β-lactam containing organic acid that serves as the **core chemical structure of all penicillin antibiotics**. It consists of a fused β-lactam-thiazolidine ring system with an amino group at position 6. Industrially, it is derived from penicillin G through enzymatic cleavage (penicillin acylases), providing the nucleus for generating semisynthetic penicillins (such as ampicillin, amoxicillin, oxacillin, carbenicillin, etc.) by substitution at the 6-amino position[1][3][7][12]. **Mechanism of action:** 6-aminopenicillanic acid itself retains the basic β-lactam mechanism—*it inhibits bacterial cell wall biosynthesis by binding and inactivating DD-transpeptidase enzymes (penicillin-binding proteins, PBPs), blocking cross-linking of peptidoglycan, leading to cell lysis and death*. However, by itself, 6-APA's antimicrobial spectrum is limited and it is primarily used as a pharmaceutical intermediate, not a finished drug[3][7][8]. Its chemical similarity to the D-Ala-D-Ala terminus of the cell wall precursors confers its mode of binding[8].

Other names
aminopenicillanic acidpeninpenicinamoxicillin related compound Aflucloxacillin EP impurity C6-amino-penicillanic acid(2S,5R,6R)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acidamoxicillin related compound A (15 mg)phenacyl 6-aminopenicillinatephenacyl6-aminopenicillinatephenacyl-6-aminopenicillinate6-aminopenicillamine acid6-aminopenicillanateamino penicillanic acid6-aminopenicin llanic acid(2s,5r,6r)-(+)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid(2s,5r,6r)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-amino-3,3-dimethyl-7-oxo-, (2s,6r)-6beta-aminopenicillanic acid
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on 6-aminopenicillanic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 6-aminopenicillanic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call